News from REMEDY

Modern medications have a good effect on adults with juvenile arthritis. However, many have reduced physical quality of life and multiple comorbidities. This is shown by research by Imane Bardan, who defended her thesis on November 3.

Do patients who use immunosuppressive medications need more corona vaccines than others? On Wednesday, December 9, 2026, Hilde Ørbo will defend her doctoral thesis in the Old Hall, University of Oslo.

The study compares different treatments for painful osteoarthritis of the thumb's root joint. The PICASSO study is the largest of its kind.

Professor emerita and senior researcher Ingvild Kjeken at Diakonhjemmet Hospital has been awarded the Norwegian Occupational Therapist Association's highest award. The honorary membership is in recognition of her many years of efforts for research, professional development and better treatment of patients.

Can a simple question about work ability say anything about future sickness absence? On November 13, 2026, Mari Nilsen Skinnes will defend her doctoral thesis, Work ability and work participation in rehabilitation, at the University of Oslo.

Most people associate juvenile idiopathic arthritis (JIA) with a disease that affects children and adolescents. But for many, the disease doesn't stop there. New research shows that the consequences can follow patients well into adulthood, affecting both health, quality of life and risk for other diseases.

How can patients with rheumatic diseases receive better and safer treatment? This has been a central question throughout Espen A. Haavardsholm's research career. Now he has been awarded the Gleditsch Prize.

Can an app support patients in their rehabilitation? And can it improve collaboration with therapists?

The researchers have investigated this in the DRIV project.

In this webinar, Kelsey Collins, PhD, presents emerging research into how adipose tissue, hormones and metabolism may influence osteoarthritis, joint damage and pain. This webinar will be available only on 30 October from 8:30 to 9:00 am.

From long hospital stays and careful escalation of medications to early targeted treatment, less stressful treatment for children and new studies on hand osteoarthritis. At the Dialogue Seminar 2026, patients, researchers and practitioners met to talk about where rheumatology stands today – and what might be next.

The title of the PhD thesis is Treatment effectiveness, health-related quality of life and long-term outcomes in adults with juvenile idiopathic arthritis

A new Norwegian study estimates that 60 percent vaccine uptake could result in 2,550 fewer cases of shingles per 10,000 people with rheumatoid arthritis after the age of 50. It also estimates 1,303 fewer cases of long-term nerve pain. The vaccine is not publicly covered.